शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
FLUOROCHEMNSEGujarat Fluorochemicals Limited· Chemicals & PetrochemicalsHighNeutral
Announced Thu, 12 Feb, 2026 · 13:35 IST

Gujarat Fluorochemicals Limited has informed the Exchange regarding Outcome of Board Meeting held on February 12, 2026.

Revenue declinedProfit growth above 25%Exceptional itemResults View source PDFExplain this filing

FLUOROCHEM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-3.7%Reaction day
₹3490.10
prior close
₹3339.00
announcement price
In-mkt
timing
Nifty Midcap 150market · index membership as recorded later (tracked since Jun 2026)-0.5%-3.2% vs market
Specialty Chemicals peers, median of 86sector-0.8%-3.0% vs sector

On the reaction day the stock moved 3.2 pts less than Nifty Midcap 150 and 3.0 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.1
10m
+0.3
15m
+0.1
30m
+0.6
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-3.7-0.5-3.2-0.8-3.0
Next day
-2.6-2.1-0.5-2.0-0.7
2d
-5.4-1.7-3.7-3.2-2.2
3d
-2.9-1.5-1.4-3.1+0.2
4d
-2.9-0.9-2.0-2.9+0.0
5d
-2.6-2.5-0.2-3.6+1.0
1w
-0.1-2.2+2.1-4.3+4.3
15d
-7.1-5.3-1.8-10.2+3.1
1m
-8.6-7.0-1.6-9.6+1.0
2m
-4.2-5.3+1.1-6.5+2.3
3m
+4.9-1.8+6.7+1.5+3.4
UpDownMarket · Nifty Midcap 150Sector · Specialty Chemicals peers, median of 86Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Gujarat Fluorochemicals reported its Q3 FY26 (quarter ended Dec 2025) unaudited results with standalone revenue of Rs. 1,026 Cr, down from Rs. 1,123 Cr in Q3 FY25. Standalone PAT stood at Rs. 127 Cr vs Rs. 153 Cr YoY. On a consolidated basis, Q3 revenue was Rs. 1,136 Cr and PAT was Rs. 102 Cr vs Rs. 126 Cr YoY. For the nine-month period, consolidated PAT grew about 31% YoY to Rs. 465 Cr, and consolidated operating margin expanded to 19.67% from 17.14% a year ago. The board recognised a one-time exceptional charge of Rs. 17 Cr related to the new Labour Codes. Mr. Vivek Jain was redesignated as Chairman and Managing Director after the passing of the previous chairman, and Deputy MD Dr. Bir Kapoor's remuneration was revised to Rs. 8 Cr per annum, subject to shareholder approval via postal ballot.

Likely market impact

Mixed quarter — Q3 revenue and profits dipped YoY on a standalone basis, but nine-month consolidated profit and margins show healthy improvement, supported by the strong Chemicals segment. The Rs. 17 Cr exceptional item is a one-time cost and not a recurring concern. The leadership transition appears orderly and is unlikely to disrupt operations; shareholders will vote on the revised remuneration soon.